Related Experiment Videos
Lung volume and pulmonary blood flow measurements following exogenous surfactant
1Department of Child Health, Kings College School of Medicine and Dentistry, London, UK.
Insights
Exogenous porcine surfactant improved infant oxygenation by increasing lung volume within 15 minutes. This enhancement in lung volume, crucial for treating surfactant deficiency, did not correlate with changes in dynamic lung compliance or pulmonary blood flow.
Area of Science:
- Neonatal Medicine
- Respiratory Physiology
- Pediatric Pulmonology
Background:
- Infant respiratory distress syndrome (RDS) is often caused by surfactant deficiency.
- Exogenous surfactant replacement therapy is a cornerstone treatment for RDS.
- Understanding the physiological impact of surfactant administration is critical for optimizing patient outcomes.
Purpose of the Study:
- To investigate the effects of exogenous porcine surfactant on lung function in infants with surfactant deficiency.
- To determine the temporal relationship between surfactant administration and changes in key respiratory parameters.
- To assess the impact of surfactant on oxygenation, lung volume, dynamic compliance, and pulmonary blood flow.
Main Methods:
- A cohort of eight infants with clinical and radiological signs of surfactant deficiency was studied.
- Lung function parameters including alveolar-arterial oxygen tension difference, dynamic lung compliance, lung volume (functional residual capacity), and effective pulmonary blood flow were measured.
- Measurements were taken before and at 15 minutes, 2 hours, and 6 hours after intratracheal administration of exogenous porcine surfactant.
Main Results:
- Significant improvement in oxygenation was observed, with a marked decrease in alveolar-arterial oxygen tension difference post-treatment (P < 0.001).
- A significant increase in functional residual capacity (lung volume) was detected within 15 minutes of surfactant administration (P = 0.009).
- No significant changes were noted in dynamic lung compliance or effective pulmonary blood flow.
Conclusions:
- Surfactant treatment improves infant oxygenation through an increase in lung volume.
- The beneficial effect on lung volume is rapid, observable within 15 minutes of administration.
- Improvements in dynamic lung compliance and pulmonary blood flow were not associated with surfactant therapy in this cohort.
Unlabelled:
Lung function in eight infants with clinical and radiological features of surfactant deficiency treated with exogenous porcine surfactant was studied before and at 15 min, 2h and 6h after the intratracheal administration of porcine surfactant. We measured alveolar-arterial oxygen tension difference, dynamic lung compliance, lung volume and effective pulmonary blood flow in all infants. The alveolar-arterial oxygen tension difference fell from a mean (SD) 43.3 (14.5) kPa before treatment to 8.8 (8.8) kPa at 1 h and 12.2 (6.8) kPa 6h after treatment (P < 0.001). There was no change in mean (SD) dynamic compliance (0.39 [0.10] ml/cmH2O/kg pre dose; 0.36 [0.13] ml/cmH2O/kg 6h post treatment). Accessible functional residual capacity and effective pulmonary blood flow were measured using an adaptation of the argon/freon rebreathing method and showed an increase in mean (SD) functional residual capacity from 7.5 (1.4) ml/kg predose to 10.8 (3.3) ml/kg within 15 min of treatment, 11.4 (3.4) ml/kg 2h later and 12.7 (3.1) ml/kg 6h after treatment (P = 0.009). Mean (SD) effective pulmonary blood flow values did not differ significantly, changing from 78.2 (20.9) ml/kg per min predose to 88.7 (24.1) ml/kg per min 15 min post dose, 87.6 (21.7) ml/kg per min 2h post dose and 90.0 (22.7) ml/kg per min 6h post dose (P = 0.711).
Conclusion:
The improvement in oxygenation after surfactant treatment is associated with an increase in lung volume but is not related to an improvement in dynamic lung compliance or effective pulmonary blood flow. The change in lung volume is detectable within 15 min of administration of the surfactant.